PL362699A1 - Zmodyfikowana protamina o obniżonej immunogeniczności - Google Patents

Zmodyfikowana protamina o obniżonej immunogeniczności

Info

Publication number
PL362699A1
PL362699A1 PL02362699A PL36269902A PL362699A1 PL 362699 A1 PL362699 A1 PL 362699A1 PL 02362699 A PL02362699 A PL 02362699A PL 36269902 A PL36269902 A PL 36269902A PL 362699 A1 PL362699 A1 PL 362699A1
Authority
PL
Poland
Prior art keywords
reduced immunogenicity
modified protamine
protamine
modified
immunogenicity
Prior art date
Application number
PL02362699A
Other languages
English (en)
Inventor
Francis J. Carr
Graham Carter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL362699A1 publication Critical patent/PL362699A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL02362699A 2001-03-08 2002-03-01 Zmodyfikowana protamina o obniżonej immunogeniczności PL362699A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01105778 2001-03-08
PCT/EP2002/002241 WO2002069997A1 (en) 2001-03-08 2002-03-01 Modified protamine with reduced immunogenicity

Publications (1)

Publication Number Publication Date
PL362699A1 true PL362699A1 (pl) 2004-11-02

Family

ID=8176722

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02362699A PL362699A1 (pl) 2001-03-08 2002-03-01 Zmodyfikowana protamina o obniżonej immunogeniczności

Country Status (12)

Country Link
US (1) US20040121443A1 (pl)
EP (1) EP1411969A1 (pl)
JP (1) JP2004520836A (pl)
KR (1) KR20030082961A (pl)
CN (1) CN1494430A (pl)
BR (1) BR0207905A (pl)
CA (1) CA2439929A1 (pl)
HU (1) HUP0303430A3 (pl)
PL (1) PL362699A1 (pl)
RU (1) RU2003129062A (pl)
WO (1) WO2002069997A1 (pl)
ZA (1) ZA200307831B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009014835A2 (en) * 2007-06-21 2009-01-29 Angelica Therapeutics, Inc. Modified toxins
US20090163437A1 (en) * 2007-10-16 2009-06-25 Regado Biosciences, Inc. Steady-state subcutaneous administration of aptamers
EP2268297A4 (en) * 2008-02-29 2011-11-16 Angelica Therapeutics Inc MODIFIED TOXINS
WO2010141771A1 (en) 2009-06-03 2010-12-09 Regado Biosciences, Inc. Nucleic acid modulators of glycoprotein vi
EP2477641B1 (en) 2009-09-16 2024-03-27 Duke University Inhibition of endosomal toll-like receptor activation for treating thrombotic disorders
SG189856A1 (en) 2010-10-14 2013-06-28 Regado Biosciences Inc Nucleic acid modulators of clec-2
US9303063B2 (en) 2011-03-18 2016-04-05 Duke University Peptide compounds for suppressing inflammation
WO2012129077A2 (en) 2011-03-18 2012-09-27 Duke University Peptides for suppressing inflammation
CN102993290B (zh) * 2012-12-12 2014-10-01 青岛亚博生物科技有限公司 反胶团法分离萃取鱼精蛋白
WO2014150600A2 (en) 2013-03-15 2014-09-25 Angelica Therapeutics, Inc. Modified toxins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2685424B2 (ja) * 1995-03-13 1997-12-03 日本水産株式会社 プロタミンの製造方法
US6624141B1 (en) * 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use

Also Published As

Publication number Publication date
CA2439929A1 (en) 2002-09-12
WO2002069997A1 (en) 2002-09-12
ZA200307831B (en) 2004-07-21
RU2003129062A (ru) 2005-04-10
KR20030082961A (ko) 2003-10-23
BR0207905A (pt) 2004-07-27
US20040121443A1 (en) 2004-06-24
EP1411969A1 (en) 2004-04-28
JP2004520836A (ja) 2004-07-15
HUP0303430A2 (hu) 2004-01-28
HUP0303430A3 (en) 2005-11-28
CN1494430A (zh) 2004-05-05

Similar Documents

Publication Publication Date Title
GB2380760B (en) Retaining member
GB0105924D0 (en) Promoter
GB0128148D0 (en) Assembly
GB2378232B (en) Polygon connection assembly
HUP0303534A3 (en) Modified interferon beta with reduced immunogenicity
PL362375A1 (pl) Zmodyfikowana leptyna o obniżonej immunogeniczności
GB0118996D0 (en) Drive Assembly
HUP0303430A3 (en) Modified protamine with reduced immunogenicity
PL363181A1 (pl) Zmodyfikowany interferon alfa o obniżonej immunogeniczności
GB0130812D0 (en) Messaging arrangement
PL372202A1 (pl) Zmodyfikowana briodyna 1 o obniżonej immunogeniczności
GB2410041B (en) Canopy
GB0128811D0 (en) Propulsion device-sky-wave
GB2376729B (en) Structural assembly
GB0104247D0 (en) Assembly
EP1400593A4 (en) NEW PROMOTER
HUP0303523A3 (en) Modified insulin with reduced immunogenicity
GB0108822D0 (en) Nail assembly
MXPA03008086A (es) Protamina modificada con inmunogenicidad reducida.
AU2003276846A8 (en) Thrombopoiesis-stimulating proteins having reduced immunogenicity
HUP0202901A2 (hu) Módosított metatézis-katalizátorok
GB0107065D0 (en) Assembly
GB0103517D0 (en) Polypeptide
GB0128814D0 (en) Plant-growing assembly
GB0117214D0 (en) Momentum lift

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)